|Year : 2014 | Volume
| Issue : 2 | Page : 52-55
Pattern of cervical dysplasia among women of reproductive age in Zaria, Northern Nigeria
Solomon Avidime1, Saad A Ahmed2, Adekunle Oguntayo1, Teni O Abu3, James A Ndako4
1 Department of Obstetrics and Gynaecology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
2 Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
3 Echoscan (Laboratory) Services Limited, Plot 643 Gimbiya Street Area 11, Federal Capital Territory, Abuja, Nigeria
4 Department of Microbiology, Landmark University PMB 1001, Omu-Aran, Kwara State, Nigeria
|Date of Web Publication||18-Aug-2014|
Dr. Saad A Ahmed
Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria
Source of Support: None, Conflict of Interest: None
Background : Cervical cancer is a preventable and the most common female genital tract cancer despite the availability of screening services for precancerous lesions of the cervix. This study aims to determine the prevalence of cervical dysplasia in women of reproductive age in Zaria.
Methodology: A prospective study of 131 women of child bearing age attending the family planning and Gynaecology clinics in Ahmadu Bello University Teaching Hospital, Zaria - Nigeria were recruited for the study after obtaining their consent. Cervical samples were collected and subjected to pap staining and cytological examination by a pathologist and classified using the Bethesda System. The data were processed using Statistical Package for the Social Sciences (SPSS) version 17. Bivariate analysis was done and the level of significance was set at a P < 0.05.
Results: Cervical dysplasia prevalence of 7.0% was found out of which High Grade Squamous Intraepithelial Lesion (HSIL) was 2.3% (n = 3), Low Grade Squamous Intraepithelial Lesion (LSIL) was 3.1% (n = 4) and Atypical Squamous Cells of Undetermined Significance (ASC-US) was 1.6% (n = 2). There were 13% (n = 17) inflammatory features. Normal cytological features for Pap smear testing was present in 77.1% (n = 101).
Conclusion: These findings underscore the importance of routine screening and early treatment of cervical dysplasia in order to reduce morbidity and mortality associated with cervical cancer.
Keywords: Cervix, dysplasia, Zaria
|How to cite this article:|
Avidime S, Ahmed SA, Oguntayo A, Abu TO, Ndako JA. Pattern of cervical dysplasia among women of reproductive age in Zaria, Northern Nigeria. J Med Trop 2014;16:52-5
|How to cite this URL:|
Avidime S, Ahmed SA, Oguntayo A, Abu TO, Ndako JA. Pattern of cervical dysplasia among women of reproductive age in Zaria, Northern Nigeria. J Med Trop [serial online] 2014 [cited 2019 Jul 22];16:52-5. Available from: http://www.jmedtropics.org/text.asp?2014/16/2/52/139045
| Introduction|| |
Cervical dysplasia is a premalignant lesion of the cervix uteri that can progress to cervical cancer over time if untreated. , The occurrence of premalignant lesion has since been well established with progression to cervical cancer in approximately 15% of cases that were not diagnosed and treated properly. , Cervical cancer is a highly preventable most common female genital tract cancer that is sexually transmitted.  The knowledge that sexually transmitted infection is a risk factor for the development of cervical cancer was as high as 62.5% in Zaria. 
The Human Papilloma virus (HPV) has been implicated to be the cause with a prevalence between 40-99.7% in all cases. , Cervical cancer account for more than 70% of female genital tract cancers in Zaria.  The progression from normal to premalignant lesion and to cervical cancer is evident in the form of cytopathic effect of variable differentiation that is detectable through routine Papanicoloau (PAP) smear staining and cytology. Pap smear was developed and named after the inventor Dr. George Papanicolaou.  The varying progression of premalignant lesions is captured by the Bethesda System which was developed by the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) in order to have a comprehensive and standardized method of classifying Pap smear results.  Whereas routine screening by the PAP smear for the premalignant lesion of cancer of the cervix has reduced the incidence of cervical cancer in developed countries, there has been poor implementation in developing countries making the disease more prevalent. ,
The documented prevalence of cervical dysplasia in literatures varies according to the population studied. Kobelin et al.,  found a prevalence of 34% particularly Squamous Intra epithelial Lesion in 406 consecutive patients mostly age 35 years who had PAP smear and cytological evaluation in Boston. In a Cameroonian study done amongst HIV Positive women, Squamous Intraepithelial Lesion (SIL) were detected in 43.5% of the 276 women with satisfactory samples and on average, women aged 26 to 59 tend to have a slightly higher prevalence of any SIL than other women in the study.  In a related evaluation of women in Sokoto,  Benin  and Ibadan,  a prevalence of 7, 16.2 and 11.8% of abnormal smear was found, respectively. Although Abdul et al.,  had previously found a prevalence of abnormal cervical smear in Zaria to be 14% while Ahmed et al.,  found LSIL and HSIL to have a prevalence of 11.1 and 4.4%, respectively, in Jalingo, North Eastern Nigeria.
The aim of this study was to determine the prevalence of cervical dysplasia among women of reproductive age attending the obstetrics and gynaecology clinics in Ahmadu Bello University Teaching Hospital, Zaria - Nigeria.
| Methodology|| |
This study was carried out over a two-month period among women of reproductive age group (15-45 years). Only sexually active women that consented to the study were included and a total of one hundred and thirty-one consecutive women attending the Family Planning and Gynaecology clinics in Ahmadu Bello University Teaching Hospital Shika, Zaria were recruited for the study. Cervical smear samples were collected and subjected to Pap staining and cytological examination by a Pathologist and classified using the Bethesda System. The data were processed using Statistical Package for the Social Sciences (SPSS) version 17. Bivariate analysis was done and the level of significance was considered at a P < 0.05.
| Results|| |
A total of 131 women were screened, majority of respondents were in the third decades of life. The overall cervical dysplasia prevalence was 7.0% in the population studied. Of the total positive smears, High Grade Squamous Intraepithelial Lesion (HSIL) was seen in 3 (2.3%) cases. The superficial and intermediate squamous cells exhibit marked increase in nuclear cytoplasmic ratio, coarse chromatin and irregular nuclear membrane [Figure 1]. Low Grade Squamous Intraepithelial Lesion (LSIL) was seen in 4 (3.1%) cases. These cells have mild nuclear enlargement, hyperchromatic nuclei and in many cases koilocytic changes [Figure 2]. Atypical Squamous Cells of Undetermined Significance (ASC-US) was seen in 1.6% (n = 2). There were 13% (n = 17) inflammatory features, which comprise reactive superficial and intermediate squamous cells, numerous polymorphs and lymphocytes. Normal cytological features for Pap smear was present in 77.1% (n = 101). Human Papillomavirus (HPV) effect was seen in 4 (3.1%) cases. HPV effect accounts for 2.5% of cases in the 30-39 years age group; and HSIL in this category accounts for 2.3% [Table 1]. There is an association between age and the occurrence of dysplasia with P < 0.5.
|Figure 2: HSIL, there is marked increase in nuclear cytoplasmic ratio (arrows), hyperchromatic nuclei displaying irregular nuclear contour. The nuclear chromatin is coarsely distributed|
Click here to view
Women in polygamous marriage have a higher prevalence of HSIL of 2.3% when compared to those in monogamous union, singles and the divorced [Table 2]. There also was an association between marriage type and the presence of cervical dysplasia with P < 0.5.
| Discussion|| |
A total of 131 women were screened and of these, our study revealed a cervical dysplasia prevalence of 7.0%. This result compares favorably with 7% prevalence value by Daniel et al.,  in Sokoto but the figure is lower that values of 11.8% and 16.2% from Ibadan  and Benin,  respectively. It was however noted that the latter studies were retrospective evaluation with larger sample size. It was noteworthy the significant decline in the prevalence of 14% to 7% abnormal smear comparing with the study of Abdul et al.,  in the same Zaria done 13 years earlier with this study, it can be reasoned that his study population were patients with pelvic inflammatory disease especially given the relation between chronic PID and cervical cancer and also that attention may have been given to risk factors for cervical cancers in this regard in the general population that this study captured. The prevalence of 34% from Atashili et al.,  in Cameroon was far higher probably because the study population was people infected with HIV.  Although there are more of LSIL 3.1% than HSIL 2.3% in the positive smear in the study, it is however observed that the LSIL are more in the younger age group (<20 years) and the HSIL in age group 30-39 years. This may probably represent the progression in the disease state over time. The same trend is observed in the Sokoto  study despite their higher percentages, but the result from Jalingo  showed higher prevalence of 11.1% in the HSIL higher than the 3.1% in this study.
Women between the ages of 20 and 39 years have higher prevalence of cervical dysplasia than younger women and literatures agreed on the increasing occurrence of abnormal smear in this age group probably related to sexual exposure and the likelihood of infection with HPV.  In this study, there is an association between increasing chronologic age and polygamy versus monogamy in the acquisition of HPV and the occurrence of cervical dysplasia with P < 0.05. This may be explained in the context that sexual activities and age are related, and there is multiplicity of sexual partner in polygamy and these combined can be a determinant for the acquisition of HPV infection and by extension cytopathic effect of such infection. 
The finding of dysplastic changes in routine cervical Pap smear screening in the population studied is significant especially considering the magnitude of cervical cancer in our setting where more often than not, patients present to hospital late. A multicentre study may provide higher prevalence. Routine cervical cancer screening using Pap smear to detect the precancerous lesion and early treatment will help reduce morbidity and mortality from cervical cancer. The importance of sexual behavioral modification that will reduce the acquisition of the HPV infections should be emphasized.
| References|| |
|1.||Marshall K. Cervical Dysplasia: Early Intervention Altern Med Rev 2003;8:156-170 |
|2.||Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36. |
|3.||zur Hausen H. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8. |
|4.||Lindeque BG. Management of cervical premalignant lesions Best Pract Res Clin Obstet Gynaecol 2005;19:545-61. |
|5.||Silverberg SG, Ioffe OB. Pathology of cervical cancer. Cancer J 2003;9:335-47. |
|6.||Ahmed SA, Sabitu K, Idris S H, Ahmed R. Knowledge, attitude and practice of cervical cancer screening among market women in zaria, Nigeria. Niger Med J 2013;54:316-9. |
|7.||Burd EM. Human Papillomavirus and Cervical Cancer. Clin Microbiol Rev 2003;16:1-17. |
|8.||Cervical cancer control in developing countries: Memorandum from a WHO meeting. Bull World Health Organ 1996;74:345-51. |
|9.||Mohammed A, Ahmed SA, Oluwole OP, Avidime S. Malignant Tumours of the Female Genital Tract in Zaria, Nigeria: Analysis of 513 Cases. Ann Afr Med 2006;5:93-6. |
|10.||Mbachu II, Umeononihu OS. The role of human papilloma virus (HPV) testing in cervical cancer screening. Afrimedic J 2012;3:1-6. |
|11.||Wright TC, Denny L, Kuhn L, Pollarl A, Lorinez A. HPV DNA testing of self-collected vaginal sample compared with cytological smear to detect cervical cancer. JAMA 2000;238:81-6. |
|12.||Huang LW, Chao SL, Chen PH, Chou HP. Multiple HPV genotypes in cervical carcinomas: Improved DNA detection and typing in archival tissues. J Clin Virol 2004;29:271-6. |
|13.||Kobelin MH, Kobelin CG, Burke L, Lavin P, Niloff JM, Kim YB. Incidence and predictors of cervical dysplasia in patients with minimally abnormal Papanicolaou smears. Obstet Gynecol 1998;92:356-9. |
|14.||Atashili J, Miller WC, Smith JS, Ndumbe PM, Ikomey GM, Eron J, et al. Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: A cross-sectional study. BMC Res Notes 2012;5:590. |
|15.||Daniel CN, Emmanuel IN, Lydia RA, Magaji A, Siddique MS. Screening for cervical cancer: Experience from a university hospital in north western Nigeria. J Basic Clin Reprod Sci 2013;2:18-21. |
|16.||Obaseki DE, Nwafor CC. Cervical cancer screening in Benin City, South-South. Nigerian J Dent Med Sci 2013;5:16-9. |
|17.||Ayinde AE, Adewole IF, Babarinsa IA. Trends in cervical cancer screening in Ibadan, Nigeria: A four-year review. West Afr J Med 1998;17:25-30. |
|18.||Abdul MA, Shittu SO, Randawa JA, Shehu MS. The cervical smear pattern in patients with chronic pelvic inflammatory disease. Niger J Clin Pract 2009;12:289-93. |
|19.||Ahmed SA, Ayuba HU, Maiangwa A, Vakkai VI, Dashe DR, Joel R, et al. Prevalence of squamous intraepithelial lesions of the cervix in jalingo, Nigeria. Afr J Cell Pathol 2013;1:19-22. |
[Figure 1], [Figure 2]
[Table 1], [Table 2]